202 related articles for article (PubMed ID: 32391261)
1. Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST.
Astolfi A; Indio V; Nannini M; Saponara M; Schipani A; De Leo A; Altimari A; Vincenzi B; Comandini D; Grignani G; Secchiero P; Urbini M; Pantaleo MA
Front Oncol; 2020; 10():504. PubMed ID: 32391261
[No Abstract] [Full Text] [Related]
2. Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).
Nannini M; Astolfi A; Urbini M; Indio V; Santini D; Heinrich MC; Corless CL; Ceccarelli C; Saponara M; Mandrioli A; Lolli C; Ercolani G; Brandi G; Biasco G; Pantaleo MA
BMC Cancer; 2014 Sep; 14():685. PubMed ID: 25239601
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
[TBL] [Abstract][Full Text] [Related]
4. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
[TBL] [Abstract][Full Text] [Related]
5. Molecular Portrait of GISTs Associated With Clinicopathological Features: A Retrospective Study With Molecular Analysis by a Custom 9-Gene Targeted Next-Generation Sequencing Panel.
Qian H; Yan N; Hu X; Jiang J; Cao Z; Shen D
Front Genet; 2022; 13():864499. PubMed ID: 35547262
[No Abstract] [Full Text] [Related]
6. Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST.
Urbini M; Indio V; Tarantino G; Ravegnini G; Angelini S; Nannini M; Saponara M; Santini D; Ceccarelli C; Fiorentino M; Vincenzi B; Fumagalli E; Casali PG; Grignani G; Pession A; Ardizzoni A; Astolfi A; Pantaleo MA
Genes Chromosomes Cancer; 2019 Sep; 58(9):636-642. PubMed ID: 30887595
[TBL] [Abstract][Full Text] [Related]
7. Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.
Gasparotto D; Rossi S; Polano M; Tamborini E; Lorenzetto E; Sbaraglia M; Mondello A; Massani M; Lamon S; Bracci R; Mandolesi A; Frate E; Stanzial F; Agaj J; Mazzoleni G; Pilotti S; Gronchi A; Dei Tos AP; Maestro R
Clin Cancer Res; 2017 Jan; 23(1):273-282. PubMed ID: 27390349
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST.
Pantaleo MA; Urbini M; Indio V; Ravegnini G; Nannini M; De Luca M; Tarantino G; Angelini S; Gronchi A; Vincenzi B; Grignani G; Colombo C; Fumagalli E; Gatto L; Saponara M; Ianni M; Paterini P; Santini D; Pirini MG; Ceccarelli C; Altimari A; Gruppioni E; Renne SL; Collini P; Stacchiotti S; Brandi G; Casali PG; Pinna AD; Astolfi A; Biasco G
Mol Cancer Res; 2017 May; 15(5):553-562. PubMed ID: 28130400
[TBL] [Abstract][Full Text] [Related]
9. Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors.
Denu RA; Joseph CP; Urquiola ES; Byrd PS; Yang RK; Ratan R; Zarzour MA; Conley AP; Araujo DM; Ravi V; Nassif Haddad EF; Nakazawa MS; Patel S; Wang WL; Lazar AJ; Somaiah N
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730662
[No Abstract] [Full Text] [Related]
10. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.
Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E
Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
12. The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST).
Nannini M; Urbini M; Astolfi A; Biasco G; Pantaleo MA
J Transl Med; 2017 May; 15(1):113. PubMed ID: 28535771
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of
Mavroeidis L; Metaxa-Mariatou V; Papoudou-Bai A; Lampraki AM; Kostadima L; Tsinokou I; Zarkavelis G; Papadaki A; Petrakis D; Gκoura S; Kampletsas E; Nasioulas G; Batistatou A; Pentheroudakis G
ESMO Open; 2018; 3(3):e000335. PubMed ID: 29636989
[TBL] [Abstract][Full Text] [Related]
14. Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTs.
Wu J; Zhou H; Yi X; He Q; Lei T; Tan F; Liu H; Li B
Cancer Manag Res; 2021; 13():297-306. PubMed ID: 33469372
[TBL] [Abstract][Full Text] [Related]
15. Genomic Study of Chinese Quadruple-negative GISTs Using Next-generation Sequencing Technology.
Wang S; Sun RZ; Han Q; Wang SY; Wang EH; Liu Y
Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):34-41. PubMed ID: 33002893
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization and pathogenesis of gastrointestinal stromal tumor.
Niinuma T; Suzuki H; Sugai T
Transl Gastroenterol Hepatol; 2018; 3():2. PubMed ID: 29441367
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors.
Gao J; Li J; Li Y; Li Z; Gong J; Wu J; Liu N; Dong B; Qi C; Li J; Shen L
Oncotarget; 2016 May; 7(21):30241-9. PubMed ID: 26848617
[TBL] [Abstract][Full Text] [Related]
18. Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.
Belinsky MG; Cai KQ; Zhou Y; Luo B; Pei J; Rink L; von Mehren M
BMC Cancer; 2017 Aug; 17(1):512. PubMed ID: 28768491
[TBL] [Abstract][Full Text] [Related]
19. [Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs].
Kalfusová A; Kodet R
Cesk Patol; 2017; 53(4):167-173. PubMed ID: 29227120
[TBL] [Abstract][Full Text] [Related]
20. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP
Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
